NCT07938086
Automated Oxygen Titration With the EMILY.AI Device During the Six-Minute Walk Test
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Study description shortened, about 12 words
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Percentage of time with SpO2 within the target range
Timeframe: Day 1
Secondary (18)
Percentage of test time with SpO2 below 88%
Number of desaturation episodes with SpO2 below 88%
Time to start of oxygen flow correction
Time to return of SpO2 to the target range
Percentage of test time with oxygen delivered while SpO2 is above 92%
Show 13 moreShow less
Number of episodes with oxygen delivered while SpO2 is above 92%
Total oxygen delivered
Mean oxygen flow
Six-minute walk distance
Change in dyspnoea measured with the modified Borg Dyspnoea Scale
Maximum heart rate
Maximum respiratory rate
Perceived difference in exercise capacity between the two tests
Perceived difference in breathlessness between the two tests
Perceived difference in comfort of oxygen delivery between the two tests
Preference between the two oxygen delivery systems
Preference for continuous automatic flow regulation at home
Preference for telemonitored home oxygen
Arms and interventions
EMILY.AI first, then fixed flowExperimental
First 6MWT with automatic titration by EMILY.AI; after 30 minutes of rest, second 6MWT with fixed-flow oxygen through the same device.
Fixed flow first, then EMILY.AIExperimental
First 6MWT with fixed-flow oxygen through the device; after 30 minutes of rest, second 6MWT with automatic titration by EMILY.AI.
Devices: EMILY.AI automatic oxygen titration
Other: Fixed-flow oxygen
Sites
1 site in 1 country
- Hospital Universitario Fundación Jiménez DíazMadrid, Spain